These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33428131)

  • 1. Cornel Iridoid Glycoside Regulates Modification of Tau and Alleviates Synaptic Abnormalities in Aged P301S Mice.
    Yang CC; Luo Y; Guo KW; Zheng CC; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1040-1046. PubMed ID: 33428131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
    Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
    Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
    Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
    Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing
    Ma D; Huang R; Guo K; Zhao Z; Wei W; Gu L; Li L; Zhang L
    Front Aging Neurosci; 2021; 13():671206. PubMed ID: 34113246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reduction of Tau Hyperphosphorylation by Cornel Iridoid Glycosides Is Mediated by Their Influence on Calpain Activity.
    Guo K; Yang C; Zhang L
    Evid Based Complement Alternat Med; 2022; 2022():9213046. PubMed ID: 35096120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cornel Iridoid glycoside attenuated brain edema of the cerebral ischemia/reperfusion rats by modulating the polarized aquaporin 4.
    Wang Z; Xue F; Zhang J; Wang Y; Hu E; Zheng Y; Luo X; Li H; Qiao B
    Fitoterapia; 2024 Sep; 177():106098. PubMed ID: 38950636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cornel Iridoid Glycoside and Its Effective Component Regulate ATPase Vps4A/JNK to Alleviate Autophagy Deficit with Autophagosome Accumulation.
    Yang CC; Zheng CC; Luo Y; Guo KW; Gao D; Zhang L; Li L; Zhang L
    Am J Chin Med; 2022; 50(6):1599-1615. PubMed ID: 35786171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
    Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
    J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cornel iridoid glycoside induces autophagy to protect against tau oligomer neurotoxicity induced by the activation of glycogen synthase kinase-3β.
    Yang C; Li X; Zhang L; Li Y; Li L; Zhang L
    J Nat Med; 2019 Sep; 73(4):717-726. PubMed ID: 31190266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction.
    Yang C; Bao X; Zhang L; Li Y; Li L; Zhang L
    Ann Transl Med; 2020 Mar; 8(6):328. PubMed ID: 32355772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.
    Yang C; Li X; Gao W; Wang Q; Zhang L; Li Y; Li L; Zhang L
    Front Pharmacol; 2018; 9():682. PubMed ID: 29997510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of cornel iridoid glycoside on behavioral impairment and senescence status in SAMP8 mice at different ages.
    Ma D; Zhu Y; Li Y; Yang C; Zhang L; Li Y; Li L; Zhang L
    Behav Brain Res; 2016 Oct; 312():20-9. PubMed ID: 27283974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
    Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
    Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
    Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
    J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
    Ozcelik S; Fraser G; Castets P; Schaeffer V; Skachokova Z; Breu K; Clavaguera F; Sinnreich M; Kappos L; Goedert M; Tolnay M; Winkler DT
    PLoS One; 2013; 8(5):e62459. PubMed ID: 23667480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piericidin A aggravates Tau pathology in P301S transgenic mice.
    Höllerhage M; Deck R; De Andrade A; Respondek G; Xu H; Rösler TW; Salama M; Carlsson T; Yamada ES; Gad El Hak SA; Goedert M; Oertel WH; Höglinger GU
    PLoS One; 2014; 9(12):e113557. PubMed ID: 25437199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
    Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M
    Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.